Pfizer Inc. will not seek emergency authorization of its coronavirus vaccine any earlier than the third week in November, when it projects it will hit important testing milestones, the company’s CEO said Friday.
Get the top stories of the day around the DMV.
Pfizer Inc. will not seek emergency authorization of its coronavirus vaccine any earlier than the third week in November, when it projects it will hit important testing milestones, the company’s CEO said Friday.